Mindy Kitei: journalist

Below is the trailer for my new book, "Shots In The Dark: An Investigation Into Covid Vaccines, Long Covid and ME/CFS.” The book’s on Amazon: amazon.com/Shots-Dark-Inv… Pls share the trailer on X.

@SandyGl88167783 No idea.

@CFSCentral What hospital?

Tradelearner explains the Saudi Arabia delay w shipping Dr. Patrick Soon-Shiong's Anktiva to treat lung cancer there. That delay is now resolved: "The Saudi 'Delay' is a Logistical Fact CEO Richard Adcock just confirmed at the Citizens Conference: Shipments were delayed by regional conflict/airspace closures. "CRITICAL: Product is READY and they have now received AIRSPACE CLEARANCE. The '60-day' window wasn't a failure of execution; it was a physical flight delay that is now RESOLVED. "The Bottom line: The Saudi Shipment (Step 2) is now cleared for takeoff." @LoriMills4CA42 @tteuscher @CarnivoreKen

@HollensbeAmanda She looks great, happy. What amazing progress.

Braelyn update Thursday March 19th Today we saw something we’ve been waiting for… For the first time in months, we’re seeing real “signs of life” in Braelyn’s right arm. She’s beginning to recruit muscles in her shoulder and triceps, and even starting to initiate some movement at the elbow. It may seem small, but this is a really big deal. 🤍 She also worked hard on more advanced gait and balance training — including walking forward and backward against resistance to challenge her coordination and control. Every day she shows up, puts in the work, and keeps pushing forward. Recovery is happening.

@LionofJudah444 @nsfmill12345 Antiparasitics are drugs as well.

@CFSCentral @nsfmill12345 Just use ANTIPARASITICS! Drugs are not our friend.

The mission of the National Comprehensive Cancer Network of 33 top cancer centers is to improve cancer treatment. It's ADDED Anktiva plus BCG for patients w papillary-only bladder cancer. Does this mean that FDA is about to approve Anktiva for papillary-only bladder cancer? Among the 33: Harvard, Yale, Stanford, UCLA, USC, Mayo, Sloan Kettering, U of Penn, Fox Chase, Johns Hopkins, Duke, St. Jude, Northwestern, U of Chicago, MD Anderson, Moffitt. Here are the rest: nccn.org/home/member-in… @CarnivoreKen @LoriMills4CA42 @tteuscher @chrisca70578779 @HollensbeAmanda @bullishbruk @mckenzielaw

@DocKeiser How did you address it, specifically?

She was told it was “just aging.” But certain head positions were reducing blood flow to her brain by ~40% and disrupting vestibular–autonomic control. Once we addressed that system, she could move normally again. Sometimes it’s not aging. It’s physiology.

@WahbaRachel Rachel, so true, and it's the funniest line I've heard all day. Thank you.

@chrisca70578779 So true. And she's no nonsense. Just the facts. And the solutions.

Here is one of the sharpest minds talking about sequestered infections. Amy Proal, in my observation, carries Polybio on her shoulders and moves Polybio forward with the help of a series of infectious disease researchers. They are headed in a direction towards answers and are in a hurry. Polybio is going to find answers and the sooner the better. Time is short for these Lyme, ME and LC patients. tickbootcamp.com/episode-558-pe… @microbeminded2 @PutrinoLab @MichaelPelusoMD @CFSCentral

47 seconds by microbiologist Dr. Amy Proal on chronic Lyme & long Covid: "The issue is in tissue." The pathogens hide in tissue. To find the pathogens, we need to develop diagnostic tests to find the pathogens in the tissue. Isn't this what researchers should be spending LC & Lyme money on? Diagnostic tests? We need markers. #longcovid #Lyme @microbeminded2

While not yet approved in China, Macau (aka Macao), a mostly autonomous city of nearly 800,000 in China, has approved Dr. Soon-Shiong's Antkiva for bladder cancer. Approval isn't limited to a particular kind of bladder cancer either. See below: #Anktiva @DrPatrick

Amazing progress. And the pride & joy on her face, what the Italians call fiero!

Braelyn update Tuesday March 17th Just 12 days after brain surgery… she’s walking independently. I am so incredibly proud of my Braelyn. 🤍 The rehab team has been amazing — they make all the hard work feel fun and keep her laughing and smiling through it all. Her therapists are truly top-notch and so creative, and we are so grateful for the care she’s receiving. She keeps showing up, putting in the work, and getting stronger every day.

We may eliminate HIV by 2030, NIH Director Bhattacharya says. That's great; HIV afflicts 40 million worldwide. BUT what about long Covid, ME/CFS & long vax? HIV has excellent drugs to control the disease. ME, LC & long vax have none. Dr. Soon-Shiong's Anktiva may work 4 them. LC afflicts 400 mil worldwide; very little attention has been paid, half a billion NIH $ wasted on "observational" studies, as if LC patients were animals in a zoo. ME arrived in the U.S. w large outbreaks at the *same* time as HIV, yet has been written off as a joke by CDC/NIH/FDA for decades. It afflicts 65 million worldwide. Long vax is scorned by legacy media, Even on X it’s a problematic subject. Conservative estimates put the disease at 1 in 800 those Covid-vaccinated, about 7 million. If the Anktiva long Covid trials are successful, that drug needs fast-tracked approval. Next, we need Anktiva trials for ME. If Anktiva works for ME, it needs to be fast-tracked too. The hallmark of ME isn't "fatigue." It's low natural killer cells. And that's what Anktiva helps restore. I discuss all this in my recent book: shotsinthedark.net @AliceOutThere @amymitchellart @julie_bush @oslersweb @chrisca70578779

@CarnivoreKen This is important step. I hope the rest of the approvals come faster, FDA will give up the "Big Pharma or nothing" ghost and will enter, at long last, the 21st century.

@CFSCentral It needs to be approved for everything.

Scroll down to "papillary only without cis." Below that it lists "Nogapendekin alfa inbakicept-pmln," code 4 Dr. Patrick Soon-Shiong's Anktiva. Looks like the cancer/antiviral drug Anktiva may *finally* be covered by insurance 4 papillary-only bladder cancer, circa 80% of cases. If this is indeed true, it's a monumental day. Next stop, Anktiva approval 4 lymphopenia (low white cell count, responsible 4 killing cancers/viruses. Among other diseases, lymphopenia occurs in HIV, Covid, long Covid, ME/CFS, herpes viruses, flu, measles, Dengue, Ebola & in cancer patients--especially when treated w traditional chemo. Lymphopenia affects at least 2.4 million in the U.S., 100-200 million worldwide. Lymphopenia is one of the best predictors of mortality & infection risk & often occurs w traditional chemotherapy & as we age. Let's go! @DrPatrick @DrMakaryFDA @CarnivoreKen @tteuscher @LoriMills4CA42 @HollensbeAmanda @AliceOutThere @julie_bush

Just papillary-only bladder cancer, circa 80% of cases. Since 2024, Anktiva's been approved for bladder cancer in situ, with or without papillary cancer. You'd think it would be a no brainer to approve for *just* papillary cancer. But since circa 80 percent of bladder cancer is papillary-only, FDA put Dr. Soon-Shiong through the wringer.

@CFSCentral This is great! Is this for any type of cancer or just what it's approved for?